G40.844
KCNQ2-related epilepsy, intractable, without status epilepticus
Clinical Classification Guidelines
Medical Intelligence & Overview
KCNQ2-related epilepsy is a neurological condition characterized by recurrent seizures caused by mutations in the KCNQ2 gene. This form of epilepsy is known for its persistent, intractable nature, meaning seizures are resistant to standard treatments. Patients with this condition often experience ongoing seizure activity without progressing to a life-threatening state called status epilepticus. Recognizing and understanding this specific type of epilepsy is important for managing symptoms and improving quality of life.
Causes & Symptoms
Clinical Causes: Mutations in the KCNQ2 gene, which plays a critical role in maintaining normal electrical activity in the brain Genetic inheritance, often inherited in an autosomal dominant pattern De novo mutations occurring spontaneously without a family history
Key Symptoms: Frequent seizures that may vary in type and severity Seizures typically begin in infancy or early childhood Myoclonic jerks or generalized convulsions Seizures resistant to many standard antiepileptic medications Lack of progression to status epilepticus in this specific subtype Delayed developmental milestones or cognitive difficulties in some cases
Diagnostic & Treatment
Diagnosis Path: Detailed medical history and neurological examination Electroencephalogram (EEG) to record electrical activity of the brain and identify seizure patterns Genetic testing to identify mutations in the KCNQ2 gene Imaging studies like MRI to rule out structural brain abnormalities
Treatment Protocols: Use of specific antiepileptic drugs that may be more effective in treating KCNQ2-related epilepsy, such as sodium channel blockers Vagus nerve stimulation or other neurostimulation techniques in refractory cases Supportive therapies, including physical, occupational, and speech therapy if developmental delays are present Regular monitoring and follow-up to assess seizure control and medication side effects Genetic counseling for affected families
Clinical Advice & FAQs
Billing Guidance
Is G40.844 a billable ICD-10 code?
Yes, G40.844 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G40.844?
Clinical documentation must specify the nature of KCNQ2-related epilepsy, intractable, without status epilepticus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference